Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Acoustic radiation force impulse (ARFI) elastography predicts the presence of esophageal varices (EVs). We investigated whether an ARFI-based prediction model can assess EV bleeding (EVB) risk in patients with cirrhosis. Methods: The records of 262 patients with cirrhosis who underwent ARFI elastography and endoscopic surveillance at two institutions in 2008 to 2013 were retrospectively reviewed, and ARFI–spleen diameter-to-platelet ratio scores (ASPS) were calculated. Results: The median patient age (165 men, 97 women) was 56 years. The median ARFI velocity, spleen diameter, platelet count, and ASPS were 1.7 m/sec, 10.1 cm, 145×109/L, and 1.16, respectively. During the median 38-month follow-up, 61 patients experienced EVB. Among all patients (179 without EVs and 83 with EVs), the cutoff value that maximized the sum of the sensitivity (73.1%) and specificity (78.4%) (area under receiver operating characteristic curve [AUROC], 0.824) for predicting EVB was 2.60. The cumulative EVB incidence was significantly higher in patients with ASPS ≥2.60 than in those with ASPS <2.60 (p<0.001). Among patients with EVs (n=83), 49 had high-risk EVs (HEVs), and 22 had EVB. The cumulative EVB incidence was significantly higher in HEV patients than in low-risk EV patients (p=0.037). At an ASPS of 4.50 (sensitivity, 66.7%; specificity, 70.6%; AUROC, 0.691), the cumulative EVB incidence was significantly higher in patients with a high ASPS than in those with a low ASPS (p=0.045). A higher ASPS independently predicted EVB (hazard ratio, 4.072; p=0.047). Conclusions: ASPS can assess EVB risk in patients with cirrhosis. Prophylactic management should be considered for patients with HEVs and ASPS ≥4.50.
Abstract
Background/Aims: Acoustic radiation force impulse (ARFI) elastography predicts the presence of esophageal varices (EVs). We investigated whether an ARFI-based prediction model can assess EV bleeding (EVB) risk in patients with cirrhosis. Methods: The records of 262 patients with cirrhosis who underwent ARFI elastography and endoscopic surveillance at two institutions in 2008 to 2013 were retrospectively reviewed, and ARFI–spleen diameter-to-platelet ratio scores (ASPS) were calculated. Results: The median patient age (165 men, 97 women) was 56 years. The median ARFI velocity, spleen diameter, platelet count, and ASPS were 1.7 m/sec, 10.1 cm, 145×109/L, and 1.16, respectively. During the median 38-month follow-up, 61 patients experienced EVB. Among all patients (179 without EVs and 83 with EVs), the cutoff value that maximized the sum of the sensitivity (73.1%) and specificity (78.4%) (area under receiver operating characteristic curve [AUROC], 0.824) for predicting EVB was 2.60. The cumulative EVB incidence was significantly higher in patients with ASPS ≥2.60 than in those with ASPS <2.60 (p<0.001). Among patients with EVs (n=83), 49 had high-risk EVs (HEVs), and 22 had EVB. The cumulative EVB incidence was significantly higher in HEV patients than in low-risk EV patients (p=0.037). At an ASPS of 4.50 (sensitivity, 66.7%; specificity, 70.6%; AUROC, 0.691), the cumulative EVB incidence was significantly higher in patients with a high ASPS than in those with a low ASPS (p=0.045). A higher ASPS independently predicted EVB (hazard ratio, 4.072; p=0.047). Conclusions: ASPS can assess EVB risk in patients with cirrhosis. Prophylactic management should be considered for patients with HEVs and ASPS ≥4.50.
참고문헌 (27)
- Garcia-Tsao G, "Portal hypertensive bleeding in cirrhosis : risk stratification, diagnosis, and management : 2016 practice guidance by the American Association for the study of liver diseases", Hepatology, 65, pp.310~335 (2017)
- Kovalak M, "Endoscopic screening for varices in cirrhotic patients : data from a national endoscopic database", Gastrointest Endosc, 65, pp.82~88 (2007)
- Groszmann RJ, "Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis", N Engl J Med, 353, pp.2254~2261 (2005)
- Merli M, "Incidence and natural history of small esophageal varices in cirrhotic patients", J Hepatol, 38, pp.266~272 (2003)
- North Italian Endoscopic Club for the Study, "Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study", N Engl J Med, 319, pp.983~989 (1988)
- Fortune BE, "Child-Turcotte-Pugh class is best at stratifying risk in variceal hemorrhage: analysis of a US multicenter prospective study", J Clin Gastroenterol, 51, pp.446~453 (2017)
- Tandon P, "Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics", Clin Gastroenterol Hepatol, 13, pp.1189~1196 (2015)
- Abraldes JG, "Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy", J Hepatol, 48, pp.229~236 (2008)
- de Franchis R, "Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop:stratifying risk and individualizing care for portal hypertension", J Hepatol, 63, pp.743~752 (2015)
- Mehta G, "Developments and controversies in the management of oesophageal and gastric varices", Gut, 59, pp.701~705 (2010)
- D’Amico G, "Pharmacological treatment of portal hypertension : an evidence-based approach", Semin Liver Dis, 19, pp.475~505 (1999)
- Kim BK, "Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model", Am J Gastroenterol, 106, pp.1654~1662 (2011)
- Bota S, "Factors associated with the impossibility to obtain reliable liver stiffness measurements by means of acoustic radiation force impulse(ARFI)elastography : analysis of a cohort of 1, 031 subjects", Eur J Radiol, 83, pp.268~272 (2014)
- Friedrich-Rust M, "Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis : a pooled meta-analysis", J Viral Hepat, 19, pp.e212~e219 (2012)
- Takuma Y, "Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices", Gastroenterology, 144, pp.92~101 (2013)
- Morishita N, "Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis", J Gastroenterol, 49, pp.1175~1182 (2014)
- Park Y, "A novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastography", PLoS One, 10, pp.e0121009~ (2015)
- Castéra L, "When the spleen gets tough, the varices get going", Gastroenterology, 144, pp.19~22 (2013)
- Garcia-Tsao G, "Now there are many(stages)where before there was one : in search of a pathophysiological classification of cirrhosis", Hepatology, 51, pp.1445~1449 (2010)
- Berzigotti A, "Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis", Gastroenterology, 144, pp.102~111 (2013)
- Bosch J, "The management of portal hypertension: rational basis, available treatments and future options", J Hepatol, 48(Suppl 1), pp.S68~S92 (2008)
- Garcia-Tsao G, "Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis", Hepatology, 46, pp.922~938 (2007)
- Marot A, "Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding", Liver Int, 37, pp.707~716 (2017)
- Buechter M, "Spleen and liver stiffness is positively correlated with the risk of esophageal variceal bleeding", Digestion, 94, pp.138~144 (2016)
- Colecchia A, "Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis", Gastroenterology, 143, pp.646~654 (2012)
- Colecchia A, "Spleen stiffness measurement can predict clinical complications in compensated HCVrelated cirrhosis : a prospective study", J Hepatol, 60, pp.1158~1164 (2014)
- Castéra L, "Pitfalls of liver stiffness measurement : a 5-year prospective study of 13, 369 examinations", Hepatology, 51, pp.828~835 (2010)